Loading…
Evonik submitted a binding bid on October 27 for METEX's entire methionine technology, including patents, bacteria strains and the inoLa brand. The bid is subject to Evonik committee approval, and both parties agreed to exclusivity.
The companies also plan to explore research cooperation on biotechnological amino acids.
The bid signals a move toward fermentation-based methionine, which could eventually add competitive supply. Near-term feed price impact is minimal.
publications.evonik.comNov 3, 2016Not enough comparable past events yet for a historical read.
Moves of each commodity's benchmark from the last close before the event. Historical reads pool past events of the same kind; they describe what happened, not what will. Not investment advice.
